Title TBA

Sophia is CEO and Chairman of Radar Therapeutics, developing the world’s most precise and powerful genetic medicines with their novel RADAR platform, the first truly programmable genetic medicine that can read a cell’s full RNA profile and only activate in the right cells, at the right time. RADAR has been recognized with awards from J&J, Eli Lilly, Abbvie, Amgen, Wacker CDMO and Science Magazine as top innovation with translational potential of the year. Sophia is also an executive committee member and board director of the international Alliance for mRNA Medicine, representing 90+ mRNA companies globally. She’s received San Francisco Business Times’ 40 under 40, Biocom Catalyst Award for top 10 disruptors of life sciences under 40, National Hispanic Institute Person of the Year, and Mendoza Impact Founder of the Year awards, and been featured on many top podcasts, publications, and equity analyst reports for the life sciences industry.